METHODS: All patients in the study underwent the novel procedure between October 2022 and July 2023. We collected data retrospectively, including patient general characteristics, surgical outcomes, and complications. Patient follow-up lasted 12 months to exclude recurrences.
RESULTS: Seventeen patients underwent the procedure for primary uncomplicated ventral hernias and rectus diastasis. The median length of hospital stay was 2 days (IQR 2-3). In 4 out of 17 cases minor complications occurred within 30 days, of which 3 were class I and 1 was a class II complication according to the Clavien-Dindo classification. There were no recurrences.
CONCLUSIONS: Although limited by a small cohort of patients and a non-comparative study design, our study presents encouraging results in regards to the safety of this technique. More studies with a larger study population are needed to evaluate the benefits and pitfalls of this new technique.[query names].
方法:研究中的所有患者在2022年10月至2023年7月期间接受了新手术。我们回顾性地收集了数据,包括患者的一般特征,手术结果,和并发症。患者随访持续12个月以排除复发。
结果:17例患者接受了原发性无并发症腹侧疝和直肌舒张的手术。中位住院时间为2天(IQR2-3)。17例中有4例在30天内发生轻微并发症,根据Clavien-Dindo分类,其中3例为I类,1例为II类并发症。没有复发。
结论:尽管受一小部分患者和非比较研究设计的限制,我们的研究在这项技术的安全性方面取得了令人鼓舞的结果.需要更多的研究人群来评估这种新技术的好处和陷阱。[查询名称]。